Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Yepes

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Neural Regeneration Research|April 14, 2016
Tissue-type plasminogen activator is a modulator of the synaptic vesicle cycleManuel Yepes
Molecular Neurobiology|October 6, 2007
TWEAK and the central nervous systemManuel Yepes
Frontiers in Cellular Neuroscience|September 9, 2015
Tissue-type plasminogen activator is a neuroprotectant in the central nervous systemManuel Yepes
Current Drug Targets|December 13, 2018
The Plasminogen Activation System Promotes Neurorepair in the Ischemic BrainManuel Yepes
Neural Regeneration Research|May 10, 2022
The uPA/uPAR system in astrocytic wound healingManuel Yepes
Neural Regeneration Research|October 23, 2019
Urokinase-type plasminogen activator is a modulator of synaptic plasticity in the central nervous system: implications for neurorepair in the ischemic brainManuel Yepes
Current Drug Targets|September 19, 2022
Neurological Complications of SARS-CoV-2 Infection and COVID-19 Vaccines: From Molecular Mechanisms to Clinical ManifestationsManuel Yepes
Frontiers in Bioscience : a Journal and Virtual Library|May 9, 2007
Tweak and FN14 in central nervous system health and diseaseManuel Yepes
Journal of Translational Neurosciences|June 26, 2018
Urokinase-type Plasminogen Activator Promotes Synaptic Recovery in the Ischemic BrainManuel Yepes
Frontiers in Immunology|November 26, 2013
TWEAK and Fn14 in the Neurovascular UnitManuel Yepes
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Neural Regeneration Research|April 14, 2016
Tissue-type plasminogen activator is a modulator of the synaptic vesicle cycleManuel Yepes
Molecular Neurobiology|October 6, 2007
TWEAK and the central nervous systemManuel Yepes
Frontiers in Cellular Neuroscience|September 9, 2015
Tissue-type plasminogen activator is a neuroprotectant in the central nervous systemManuel Yepes
Current Drug Targets|December 13, 2018
The Plasminogen Activation System Promotes Neurorepair in the Ischemic BrainManuel Yepes
Neural Regeneration Research|May 10, 2022
The uPA/uPAR system in astrocytic wound healingManuel Yepes
Neural Regeneration Research|October 23, 2019
Urokinase-type plasminogen activator is a modulator of synaptic plasticity in the central nervous system: implications for neurorepair in the ischemic brainManuel Yepes
Current Drug Targets|September 19, 2022
Neurological Complications of SARS-CoV-2 Infection and COVID-19 Vaccines: From Molecular Mechanisms to Clinical ManifestationsManuel Yepes
Frontiers in Bioscience : a Journal and Virtual Library|May 9, 2007
Tweak and FN14 in central nervous system health and diseaseManuel Yepes
Journal of Translational Neurosciences|June 26, 2018
Urokinase-type Plasminogen Activator Promotes Synaptic Recovery in the Ischemic BrainManuel Yepes
Frontiers in Immunology|November 26, 2013
TWEAK and Fn14 in the Neurovascular UnitManuel Yepes
Pageof 9